[PDF][PDF] mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

…, AD Nitido, ML Sheehan, C Berrios, O Ofoman… - Cell, 2022 - cell.com
Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.1/B.1.1.529)
harboring up to 36 mutations in spike protein, the target of neutralizing antibodies…

[PDF][PDF] T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals

…, A Khatri, S Choi, MA Getz, R Tano-Menka, O Ofoman… - Cell, 2022 - cell.com
The SARS-CoV-2 Omicron variant (B.1.1.529) contains mutations that mediate escape from
antibody responses, although the extent to which these substitutions in spike and non-spike …

[HTML][HTML] Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer: the CANVAX cohort study

…, C Bowes, CJ Berrios-Mairena, O Ofoman… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
PURPOSE The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients
with cancer are poorly understood. METHODS We performed a prospective cohort study of …

[PDF][PDF] Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer

V Naranbhai, KJS Denis, EC Lam, O Ofoman… - Cancer cell, 2022 - cell.com
Patients with cancer are more likely to have impaired immune responses to SARS-CoV-2
vaccines. We study the breadth of responses against SARS-CoV-2 variants after primary …

Response to severe acute respiratory syndrome coronavirus 2 initial series and additional dose vaccine in patients with predominant antibody deficiency

…, PE Hesterberg, RR Saff, J MacLean, O Ofoman… - The Journal of Allergy …, 2022 - Elsevier
… Saff MD, PhD a b , James MacLean MD h , Onosereme Ofoman BS d , Cristhian Berrios
MD d , Kerri J. St Denis BS i , Evan C. Lam BS i , David Gregory PhD j k , Anthony John Iafrate …

Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein

…, MA Getz, F Senjobe, C Berrios, O Ofoman… - medRxiv, 2022 - medrxiv.org
In previously unvaccinated and uninfected individuals, non-RBD SARS-CoV-2 spike-specific
B cells were prominent in two distinct, durable, resting, cross-reactive, “pre-existing” …

[CITATION][C] T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals (preprint)

…, A Khatri, S Choi, M Getz, R Tano-Menka, O Ofoman… - 2022

[PDF][PDF] Alejandro B. Balazs, Ph. D.

C Laude - 2006 - balazslab.partners.org
13. Naranbhai V, Denis KJ, Lam EC, Onosereme O, Garcia-Beltran WF, Berrios C, Bhan AK,
Gainor JF, Balazs AB, Iafrate AJ. Neutralization breadth of SARS-CoV-2 viral variants …

Detection of SARS-CoV-2 main variants of concerns using deep learning

M Togrul, H Arslan - 2022 Innovations in Intelligent Systems …, 2022 - ieeexplore.ieee.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a big effect
on worldwide and is responsible for the coronavirus disease 2019 (COVID-19). The novel …

[HTML][HTML] Medicine Must Collaborate to End the Pandemic

S Jeejeebhoy, AFT Wear, S Peek, JT Story… - jeejeebhoy.ca
Whole-Picture Thinking is missing from the global pandemic response, except here and
there, for medicine has devolved into sub-sub-specialties. Like the endocrinologist who …